Heron Therapeutics Inc.

NASDAQ: HRTX · Real-Time Price · USD
1.33
-0.02 (-1.48%)
At close: Aug 15, 2025, 3:59 PM
1.33
-0.23%
After-hours: Aug 15, 2025, 05:03 PM EDT

Heron Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
25.8M 28.68M 15.36M 90.54M
Short-Term Investments
33.48M 51.73M 69.49M 67.04M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
6.48M 8.13M 15.71M 17.72M
Receivables
78.88M 60.14M 52.05M 35.5M
Inventory
53.16M 42.11M 54.57M 48.38M
Other Current Assets
17.69M 6.12M 13.96M n/a
Total Current Assets
209.01M 188.77M 205.44M 254.42M
Property-Plant & Equipment
17.65M 25.6M 29.8M 33.56M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
24.13M 33.73M 45.52M 51.28M
Total Assets
233.15M 222.51M 250.95M 305.71M
Account Payables
11.71M 3.24M 3.23M 3.8M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
3.04M 3.08M 2.69M 2.42M
Other Current Liabilities
73.67M 61.07M 60.33M 47.16M
Total Current Liabilities
91.46M 79.69M 82.36M 71.06M
Long-Term Debt
174.73M 173.75M 149.28M 149.08M
Other Long-Term Liabilities
615K 241K 241K n/a
Total Long-Term Liabilities
175.34M 176.79M 155.02M 157.08M
Total Liabilities
266.8M 256.48M 237.38M 228.14M
Total Debt
177.76M 179.63M 157.48M 159.5M
Common Stock
1.52M 1.5M 1.19M 1.02M
Retained Earnings
-1.92B -1.91B -1.8B -1.61B
Comprehensive Income
13K 13K -19K -6K
Shareholders Equity
-33.65M -33.97M 13.57M 77.57M
Total Investments
33.48M 51.73M 69.49M 67.04M